Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis - No Study Results Posted - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

This study has been completed.

Study NCT00027300 Information provided by Biogen Idec

First Received: November 30, 2001 Last Updated: June 15, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	January 2005
Primary Completion Date:	November 2004 (Final data collection date for primary outcome measure)

Publications:

Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006 Mar 2;354(9):899-910.

Back to top of Main Content